Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients

*

Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK

Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK

*

Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK

Kingmed College of Laboratory Medicine, Guangzhou Medical University, Guangzhou, China

Department of Clinical Medicine, Medical School, Xiangnan University, Chenzhou, China

Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, Basel, Switzerland

Research Center for Clinical Neuroimmunology and Neuroscience, University of Basel, Basel, Switzerland

Pharmacy Department, The Royal London Hospital, Barts Health NHS Trust, London, UK

Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK

Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK

Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK

Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK

Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK

Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK

Neuroradiology Department, The Royal London Hospital, Barts Health NHS Trust, London, UK

Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK

St George’s University Hospitals NHS Foundation Trust, London, UK

Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK

The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK

Department of Neurology, Nottingham University Hospitals NHS Trust, Nottingham, UK

Mental Health and Clinical Neuroscience Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK

St George’s University Hospitals NHS Foundation Trust, London, UK

The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK

Department of Neuroinflammation, National Hospital for Neurology and Neurosurgery, London, UK

Brighton and Sussex University Hospitals NHS Trust, Brighton, UK; Brighton and Sussex Medical School, Brighton, UK

Leeds Teaching Hospitals NHS Trust, Leeds, UK

Department of Neurology, Nottingham University Hospitals NHS Trust, Nottingham, UK

Mental Health and Clinical Neuroscience Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK

Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK

Department of Neuroinflammation, National Hospital for Neurology and Neurosurgery, London, UK

Queen’s Hospital, Barking Havering and Redbridge Hospital NHS Trust, Romford, UK; Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK

Dental Translational and Clinical Research Unit, School of Dentistry, University of Leeds, Leeds, UK

Department of Neurology, Swansea Bay University Health Board, Port Talbot, UK

Department of Clinical Neurosciences and National Institute for Health Research (NIHR) Biomedical Research Centre, University of Cambridge, Cambridge, UK

Centre of Neuroscience, Department of Medicine Charing Cross Hospital, Imperial College London, London, UK

Department of Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

Department of Neuroscience and NIHR Neurosciences Biomedical Research Centre, University of Sheffield, Sheffield, UK

Department of Neurology, King’s College Hospital, London, UK

Department of Neurology, University Hospital of Wales, Cardiff, UK

Division of Psychological Medicine and Clinical Neuroscience, School of Medicine, Cardiff University, Cardiff, UK

Institute of Neuroscience, Department of Neurology, Queen Elizabeth University Hospital, Glasgow, UK

Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK

Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK

Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK

Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK

Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK

Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK

Department of Hematology, Skåne University Hospital, Lund, Sweden

Stem Cell Centre, Department of Laboratory Medicine, Lund University, Lund, Sweden

Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK

Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK

Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK

Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AT, UK


留言 (0)

沒有登入
gif